Clovis Oncology
CLVS
$0.08120
Share price
0.00%
Change (1 day)
-95.08%
Change (1 year)
Categories
Clovis Oncology (CLVS) - Total debt
Total debt on the balance sheet as of September 2022 : $0.68 B
According to Clovis Oncology's latest financial reports the company's total debt is $0.68 B. A company’s total debt is the sum of all current and non-current debts.
Clovis Oncology - Total debt on balance sheet (from 2011 to 2022)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2021-12-31 | $0.63 B | -1.32% |
| 2020-12-31 | $0.64 B | -9.47% |
| 2019-12-31 | $0.71 B | 23.96% |
| 2018-12-31 | $0.57 B | 104.14% |
| 2017-12-31 | $0.28 B | 0.46% |
| 2016-12-31 | $0.28 B | 0.44% |
| 2015-12-31 | $0.27 B | -2.65% |
| 2014-12-31 | $0.28 B |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $29.33 B | 4,209.60% | 🇺🇸 USA |
 Pfizer PFE | $70.84 B | 10,308.89% | 🇺🇸 USA |
 AbbVie ABBV | $59.38 B | 8,625.13% | 🇺🇸 USA |
 Eli Lilly LLY | $25.22 B | 3,606.22% | 🇺🇸 USA |
 AstraZeneca AZN | $34.55 B | 4,976.40% | 🇬🇧 UK |
 BioMarin Pharmaceutical BMRN | $1.09 B | 60.99% | 🇺🇸 USA |